Page last updated: 2024-08-23

nafazatrom and Arterial Occlusive Diseases

nafazatrom has been researched along with Arterial Occlusive Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Buchanan, MR; Butt, RW; Turpie, AG	1

Trials

1 trial(s) available for nafazatrom and Arterial Occlusive Diseases

Article	Year
Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease. American heart journal, 1987, Volume: 113, Issue:5 Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Aged; Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Epoprostenol; Humans; Hydroxyeicosatetraenoic Acids; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Pyrazoles; Pyrazolones; Random Allocation; Thromboxane B2	1987

Article

Year

Effect of nafazatrom on platelet function and release: relationship to symptomatic episodes in patients with peripheral vascular disease.

American heart journal, 1987, Volume: 113, Issue:5

Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Adult; Aged; Arterial Occlusive Diseases; beta-Thromboglobulin; Blood Platelets; Clinical Trials as Topic; Double-Blind Method; Drug Administration Schedule; Epoprostenol; Humans; Hydroxyeicosatetraenoic Acids; Middle Aged; Platelet Adhesiveness; Platelet Aggregation; Pyrazoles; Pyrazolones; Random Allocation; Thromboxane B2

1987